The DEGs were intersected with the hub genes from hdWGCNA to obtain three key genes for GBM, namely, NFKBIA, NR4A2, and FOSB. These three genes were used to establish a robust and reliable diagnostic model, and they bound to the drug candidate thalidomide. This evidence concerns the gene NFKBIA and glioblastoma.